In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Pfizer, which has operations in St. Louis, said in a ...